Innovent has 10 products in the market, including TYVYT (Sintilimab Injection), BYVASDA (Bevacizumab Injection), SULINNO (Adalimumab Injection), HALPRYZA (Rituximab Injection), Pemazyre (Pemigatinib Oral Inhibitor), Olverembatinib, Cyramza (Ramucirumab Injection), Retsevmo (Selpercatinib Capsules ), FUCASO (Equecabtagene Autoleucel Injection) and SINTBILO (Tafolecimab Injection).Additionally, we have 2 assets are under NMPA NDA review, 5 assets are in Phase III or pivotal clinical trials, and 19 more molecules in early clinical stage
Known under brand names such as Wegovy and Ozempic, semaglutide has been lauded for its dual actionslowing stomach emptying and enhancing feelings of fullness, helping you control your calorie intake naturally
Intervention of sodium aescinate on experimental pneumonedema of rats
A full evaluation with a healthcare provider is required to confirm if retatrutide is appropriate, and success hinges on combining medication with sustainable lifestyle adjustments